P. Antosik

发表

KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system

P. Sadłecki, P. Antosik, D. Grzanka, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma

P. Antosik, D. Grzanka, Adam Kowalewski, 2018, Pathology & Oncology Research.

TRIP13 predicts poor prognosis in clear cell renal cell carcinoma.

P. Antosik, D. Grzanka, Adam Kowalewski, 2020, American journal of cancer research.

Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review

P. Antosik, Adam Kowalewski, Łukasz Szylberg, 2017, Journal of immunology research.

Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patients

P. Antosik, D. Grzanka, M. Braun, 2022, Journal of Cancer Research and Clinical Oncology.

Emerging strategies in BRCA-positive pancreatic cancer

P. Antosik, D. Grzanka, Adam Kowalewski, 2018, Journal of Cancer Research and Clinical Oncology.

Short Term Pre-Operative Oral Corticosteroids—Tissue Remodeling in Chronic Rhinosinusitis with Nasal Polyps

P. Antosik, D. Grzanka, Marek Zdrenka, 2021, Journal of clinical medicine.

Markers of pancreatic cancer stem cells and their clinical and therapeutic implications

P. Antosik, D. Grzanka, Łukasz Szylberg, 2019, Molecular Biology Reports.

HA PEGylated Filler in Association with an Infrared Energy Device for the Treatment of Facial Skin Aging: 150 Day Follow-Up Data Report

M. Protasoni, P. Antosik, D. Grzanka, 2022, Pharmaceuticals.

The scaning electron microscopy of the development of the tongue in the pheasant (Phasianus colchicus)

P. Antosik, H. Jackowiak, S. Godynicki, 2004 .

HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters

P. Antosik, D. Grzanka, J. Jóźwicki, 2019, Disease markers.

Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer

P. Antosik, D. Grzanka, M. Gagat, 2021, Journal of Cancer.

Prognostic Significance of SATB1, SMAD3, Ezrin and β-Catenin in Patients with Pancreatic Adenocarcinoma

P. Antosik, D. Grzanka, Wioletta Zielińska, 2021, Applied Sciences.

Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non–Small-Cell Lung Cancer Patients

P. Antosik, D. Grzanka, Adam Kowalewski, 2021, Cancer control : journal of the Moffitt Cancer Center.

Expression differences between proteins responsible for DNA damage repair according to the Gleason grade as a new heterogeneity marker in prostate cancer

P. Antosik, D. Grzanka, Łukasz Szylberg, 2019, Archives of medical science : AMS.

The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice.

P. Antosik, D. Grzanka, Łukasz Szylberg, 2020, Urologic oncology.

Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer

P. Sadłecki, P. Antosik, M. Walentowicz-Sadłecka, 2020, BioMed research international.

Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test

P. Antosik, D. Grzanka, Łukasz Szylberg, 2020, Disease markers.

The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers.

P. Antosik, D. Grzanka, Łukasz Szylberg, 2021, Clinics and research in hepatology and gastroenterology.

Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma

P. Antosik, D. Grzanka, Justyna Durślewicz, 2023, Biomedicines.

Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma

P. Antosik, D. Grzanka, M. Gagat, 2021, Cancers.

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

P. Sadłecki, P. Antosik, D. Grzanka, 2019, Journal of Ovarian Research.

Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms

P. Antosik, M. Wierzbicka, M. Jarmuż-Szymczak, 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Urinary bladder augmentation with acellular biologic scaffold-A preclinical study in a large animal model.

P. Antosik, D. Grzanka, J. Skopińska-Wiśniewska, 2021, Journal of biomedical materials research. Part B, Applied biomaterials.

TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma

P. Antosik, D. Grzanka, Adam Kowalewski, 2022, International journal of molecular sciences.

The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer

P. Antosik, D. Grzanka, Łukasz Szylberg, 2020, Journal of Cancer Research and Clinical Oncology.

A tissue-engineered urinary conduit in a porcine urinary diversion model

P. Antosik, D. Grzanka, M. Pokrywczyńska, 2021, Scientific Reports.

Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers

P. Sadłecki, P. Antosik, M. Grabiec, 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

The Prognostic Role of CDK9 in Bladder Cancer

P. Antosik, Marek Zdrenka, Łukasz Szylberg, 2022, Cancers.

Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options

P. Antosik, Łukasz Szylberg, A. Marszałek, 2020, Journal of immunology research.

The development of marine biomaterial derived from decellularized squid mantle for potential application as tissue engineered urinary conduit.

M. Stopel, P. Antosik, D. Grzanka, 2020, Materials science & engineering. C, Materials for biological applications.

High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients

P. Antosik, D. Grzanka, M. Braun, 2022, Discover Oncology.

Cellular and molecular alterations induced by low-dose fisetin in human chronic myeloid leukemia cells

P. Antosik, D. Grzanka, M. Gagat, 2019, International journal of oncology.

Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors

P. Antosik, U. Pasławska, R. Pasławski, 2024, Applied Sciences.

KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system

P. Sadłecki, P. Antosik, D. Grzanka, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

The Prognostic Role of ACO2 in Renal Cell Carcinoma

P. Antosik, D. Grzanka, Adam Kowalewski, 2023, AntiCancer Research.

Overexpression of kif11 is a poo r prognostic factor in clear cell renal cell carcinoma.

P. Antosik, D. Grzanka, Adam Kowalewski, 2022, Polish journal of pathology : official journal of the Polish Society of Pathologists.